Mucosal Th1- versus Th2-type responses for antibody- or cell-mediated immunity to simian immunodeficiency virus in rhesus macaques

Journal of Infectious Diseases

Volumn 179, Issue SUPPL. 3, 1999, Pages

  McGhee, Jerry R ^a,b,c,d,e   Kiyono, Hiroshi ^a,b,c,d   Kubota, Mitsuru ^a,b,c,d   Kawabata, Shigetada ^a,b,c,d   Miller, Christopher J ^a,b,c,d   Lehner, Thomas ^a,b,c,d   Imaoka, Koichi ^a,b,c,d   Fujihashi, Kohtaro ^a,b,c,d  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; CYTOKINE; GAG PROTEIN; GAMMA INTERFERON; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 6; PROTEIN P27; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCING CELL; ANTIBODY RESPONSE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; IMMUNIZATION; LYMPH NODE; MONONUCLEAR CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; GENE PRODUCTS, GAG; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; LYMPH NODES; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS; TH1 CELLS; TH2 CELLS; VIRAL VACCINES;

EID: 0032896851     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314807     Document Type: Conference Paper

References (20)

1. 1. Lehner T, Miller CJ. Rectal and genital immunization with SIV/HIV. In: Kiyono H, Ogra PL, McGhee JR, eds. Mucosal vaccines. San Diego: Academic Press, 1996:357-71.
2. 2. Jackson RJ, Fujihashi K, Xu-Amano J, Kiyono H, Elson CO, McGhee JR. Optimizing oral vaccines: induction of systemic and mucosal B cell and antibody responses to tetanus toxoid by use of cholera toxin as adjuvant. Infect Immun 1993; 61:4272-9.
3. 3. Tristram DA, Ogra PL. Genital tract infection: implications in the prevention of maternal and fetal disease. In: Ogra PL, Mestecky J, Lamm ME, et al., eds. Handbook of mucosal immunology. San Diego: Academic Press, 1994:729-44.
4. 4. Lehner T, Bergmeier LA, Panagiotidi C, et al. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 1992; 258:1365-9.
5. 5. Lehner T, Brookes R, Panagiotidi C, et al. T-and B-cell functions and epitope expression in nonhuman primates immunized with simian immunodeficiency virus antigen by the rectal route. Proc Natl Acad Sci USA 1993; 90:8638-42.
6. 6. Lehner T, Bergmeier LA, Tao L, et al. Targeted lymph node immunization with simian immunodeficiency virus p27 antigen on elicit genital, rectal, and urinary immune responses in nonhuman primates. J Immunol 1994; 153:1858-68.
7. 7. Lehner T, Wang Y, Cranage M, et al. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nat Med 1996; 2:767-75.
8. 8. Elson CO. Cholera toxin as a mucosal adjuvant In: Kiyono H, Ogra PL, McGhee JR, et al., eds. Mucosal vaccines. San Diego: Academic Press, 1996:59-72.
9. 9. Xu-Amano J, Kiyono H, Jackson RJ, et al. Helper T cell subsets for immunogiobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 1993; 178:1309-20.
10. 10. Kawabata S, Miller CJ, Lehner T, et al. Induction of Th2 cytokine expression for p27-specific IgA B cell responses after targeted lymph node immunization with simian immunodeficiency virus antigens in rhesus macaques. J Infect Dis 1998; 177:26-33.
11. 11. Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7:145-73.
12. + T cells. Annu Rev Immunol 1994; 12:635-73.
13. 13. Beagley KW, Eldridge JH, Lee F, et al. Interleukins and IgA synthesis: human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med 1989; 169:2133-48.
14. 14. Fujihashi K, McGhee JR, Lue C, et al. Human appendix B cells naturally express receptors for and respond to interleukin 6 with selective IgA1 and IgA2 synthesis. J Clin Invest 1991; 88:248-52.
15. PAP and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primates. J Immunol 1997; 158:5321-9.
16. 16. Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTL and protection against tumor development in vivo. J Immunol 1997; 158:834-41.
17. 17. Lohman BL, Miller CJ, McChesney MB. Antiviral cytotoxic T lymphocytes in the vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J Immunol 1995; 155:5855-60.
18. 18. McGhee JR, Mestecky J, Elson CO, Kiyono H. Regulation of IgA synthesis and immune response by T cells and interleukins. J Clin Immunol 1989; 9: 175-99.
19. 19. Briére F, Bridon JM, Chevet D, et al. Interleukin 10 induces B lymphocytes from IgA-deficient patients to secrete IgA. J Clin Invest 1994; 94:97-104.
20. 20. Kollmann TR, Pettoello-Mantovani M, Katopodis NF, et al. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver. Proc Natl Acad Sci USA 1996; 93:3126-31.